Skip to main content
The Journal of Physiology logoLink to The Journal of Physiology
. 2016 Jun 1;594(11):2779–2780. doi: 10.1113/JP272063

Balancing SR Ca2+ uptake and release in the cycle of heart rhythm

D R Laver 1
PMCID: PMC4887683  PMID: 27246543

Heart contraction is normally initiated by spontaneous action potentials in the sinoatrial node (SAN, the pacemaker region), which propagate through the heart via electrical connections between cells. Proper timing of initiation and propagation of action potentials is crucial for the coordinated contraction of atria and ventricles necessary for blood circulation.

The cardiac action potential triggers a rise in cytoplasmic [Ca2+] that stimulates muscle contraction (Bers, 2002). This occurs by opening voltage‐dependent L‐type Ca2+ channels (LCCs) in the sarcolemma and transverse tubules. The resulting influx of Ca2+ into the cytoplasm activates Ca2+ release in the sarcoplasmic reticulum (SR) at specialised intracellular synapses (dyad junctions) between transverse tubules and SR. Elevated [Ca2+] in the cytoplasm of the dyad cleft activates cardiac Ca2+ release channels (Type 2 ryanodine receptors, RyR2) in the SR membrane via their cytoplasmic facing activation sites. The subsequent release of Ca2+ from the SR into the dyad cleft feeds back on RyR2 to cause further activation (Fabiato, 1983). This Ca2+‐induced Ca2+ release (CICR) provides a strong positive feedback on Ca2+ release that is ultimately broken by Ca2+ depletion within subcompartments of the SR associated with the dyad junction (Guo et al. 2012; Laver et al. 2013). Once RyR2s deactivate, [Ca2+] in the cytoplasm declines as Ca2+ is either pumped back into the SR by ATP driven Ca2+ pumps in the SR membrane (SERCA2a) or extruded from the cell by the Na+/Ca2+ exchanger (NCX) in the sarcolemma, allowing muscle relaxation.

The cardiac action potential normally drives the cyclic release and uptake of Ca2+ by the SR (Ca2+ cycling) in ventricular cells, as described above. However, in cells of the SAN, SERCA2a can increase [Ca2+] in the SR lumen to the point where it can activate RyR2 via luminal facing sites on RyR2. The NCX, that extrudes 1 Ca2+ in exchange for 3 Na+, contributes to depolarisation of the sarcolemma and the triggering of action potentials, thus providing a link by which Ca2+ cycling can advance or retard spontaneous action potentials. There is now substantial evidence that this process plays a key role in heart pacemaking and that coordinated increases in RyR2 and SERCA2a activity during stress and exercise contribute to increased heart rate (Rigg and Terrar, 1996; Ju and Allen, 2007; Lakatta and DiFrancesco, 2009). However, pathological over‐activation of RyR2 due to inherited mutations in RyR2, certain drugs or chemical modifications of RyR2 that occur during or following ischaemia (periods of reduced blood flow) or during heart failure causes heart arrhythmias and sudden cardiac death (Blayney and Lai, 2009; Belevych et al. 2012). Thus, excess RyR2 activity tends to promote SAN‐like Ca2+ cycling in ventricular myocytes, leading to alternative foci for pacemaking and arrhythmia.

Our understanding of the role of SR Ca2+ uptake in maintaining heart rhythm is hampered by conflicting experimental findings. Many studies show that increasing Ca2+ uptake by increased SERCA2a expression protects against Ca2+‐driven action potentials and arrhythmias and that inhibition of SERCA2a is proarrhythmic, while other studies show that decreasing Ca2+ uptake is protective. The paper by Mazzocchi et al. (2016) in this issue of The Journal of Physiology has addressed the role of SR Ca2+ uptake in maintaining heart rhythm using both experimental and computational modelling approaches. They used a knockout mouse, deficient in the SERCA2a inhibiting protein, phospholamban (PLN), to assess the effects of SERCA2a up‐regulation on the incidence of adrenergically induced arrhythmic events in intact hearts and on Ca2+ cycling and action potentials in ventricular cardiac cells. By crossing PLN knockout mice with RyR2 knockin mice containing a pseudo‐phosphorylation S2814D mutation, they were able to test if increased Ca2+ uptake could prevent arrhythmic events due to excess Ca2+ release. Their resultant data confirmed this hypothesis showing that it is possible to compensate the pathological effects of excess Ca2+ release by increasing Ca2+ uptake.

From the literature, it appears that the roles of the main Ca2+ transport proteins (RyR2, SERCA2a, NCX and LCC) involve complex interactions between their transport functions as well as Ca2+ diffusion and buffering in the cytoplasm and SR lumen. To understand these interactions and their role in heart function, Mazzocchi et al. rely on a computer model of human ventricular myocytes that incorporates the function of these transporters into a simplified dyad and cell structure. Their model simulates their experimentally observed properties of cardiac action potentials, Ca2+ cycling and the incidence of arrhythmia events in isolated myocytes from wild‐type and genetically modified mice. Importantly, this model successfully predicts their experimental observation that increased SERCA2a activity in the PLN‐deficient mouse protects against arrhythmias generated by excess Ca2+ release in the S2814D mutation in RyR2. A particularly interesting output of their model was a heat map of arrhythmia incidence in relation to imposed changes in SR Ca2+ uptake and release. The map shows an island of increased arrhythmia incidence between 50% and 600% increase in RyR2 activity and between ±20% changes in SERCA2a activity. In other words, either increasing or decreasing SERCA2a activity by more than 20% can rescue the S2814D mouse from arrhythmia events. Interrogation of their model revealed that increasing SERCA2a activity increases the rate of Ca2+ removal from the cytoplasm, both decreasing cytoplasmic [Ca2+] and stimulating NCX interactions with action potentials, whereas decreasing SERCA2a activity reduces Ca2+ loading of the SR and hence luminal [Ca2+] and resultant RyR2 activity, these changes also resulting in a decreased cytoplasmic [Ca2+]. The predictions go some way to explaining the contradictory experimental findings on the effect of SERCA2a activity on heart rhythm and provide an outstanding example of how experimental studies in combination with computational modelling can illuminate complex cellular processes.

Additional information

Competing interests

None declared.

References

  1. Belevych AE, Terentyev D, Terentyeva R, Ho HT, Gyorke I, Bonilla IM, Carnes CA, Billman GE & Gyorke S (2012). Shortened Ca2+ signaling refractoriness underlies cellular arrhythmogenesis in a postinfarction model of sudden cardiac death. Circ Res 110, 569–577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bers DM (2002). Cardiac excitation‐contraction coupling. Nature 415, 198–205. [DOI] [PubMed] [Google Scholar]
  3. Blayney LM & Lai FA (2009). Ryanodine receptor‐mediated arrhythmias and sudden cardiac death. Pharmacol Ther 123, 151–177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fabiato A (1983). Calcium‐induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol Cell Physiol 245, C1–C14. [DOI] [PubMed] [Google Scholar]
  5. Guo T, Gillespie D & Fill M (2012). Ryanodine receptor current amplitude controls Ca2+ sparks in cardiac muscle. Circ Res 111, 28–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ju YK & Allen DG (2007). Store‐operated Ca2+ entry and TRPC expression; possible roles in cardiac pacemaker tissue. Heart Lung Circ 16, 349–355. [DOI] [PubMed] [Google Scholar]
  7. Lakatta EG & DiFrancesco D (2009). What keeps us ticking: a funny current, a calcium clock, or both? J Mol Cell Cardiol 47, 157–170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Laver DR, Kong CHT, Imtiaz MS & Cannell MB (2013). Termination of calcium‐induced calcium release by induction decay: An emergent property of stochastic channel gating and molecular scale architecture. J Mol Cell Cardiol 54, 98–100. [DOI] [PubMed] [Google Scholar]
  9. Mazzocchi G, Sommese L, Palomeque J, Felice JI, Di Carlo MN, Fainstein D, Gonzalez P, Contreras P, Skapura D, McCauley MD, Lascano EC, Negroni JA, Kranias EG, Wehrens X, Valverde CA, Mattiazzi A (2016). Phospholamban ablation rescues the enhanced propensity to arrhythmias of mice with CaMKII‐constitutive phosphorylation of RyR2 at site S2814. J Physiol 594, 3005–3030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rigg L & Terrar DA (1996). Possible role of calcium release from the sarcoplasmic reticulum in pacemaking in guinea‐pig sino‐atrial node. Exp Physiol 81, 877–880. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES